Home >
FEATURED BLOGS
Jan 05, 2017
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit...
Jan 13, 2017
The inaugural ASCO-SITC Clinical Immuno-Oncology Symposium will have three networking sessions, designed to help physicians determine how immunotherapy best fits into their practice, and to explore...
Jan 10, 2017
When faced with a diagnosis of cancer, my patients and their families show more courage than I could ever have imagined.
Jan 04, 2017
Dr. Maher Saifo, an oncologist practicing in Syria, discusses how the Syrian war is affecting cancer care in a post written with his patient, Lama Meer Yousef. Together, they share their story of...
Dec 27, 2016
With new therapies, fortunately, oncologists are now seeing patients over the span of years, and we get to know the person who is the patient beyond their illness. Many also bring along others on...
Dec 22, 2016
When I first took the helm of ASCO’s member publication in 2006, ASCO Connection was very different—so different, in fact, that it was not even called ASCO Connection!
Dec 21, 2016
I cannot count the number of times I have thought to myself, “If it were not for the PSA, you would no doubt be out there playing golf, skiing, biking, taking a grandchild to the park, or just...
Dec 16, 2016
ASCO provides answers to some of the most frequently asked questions about the Society's proposed pathway for Maintenance of Certification, in response to your insightful feedback.

Latest Comments & Discussions


ASCO University
Jan 16, 2017
Discussion Questions 1. What is known about the pathological and molecular characterization of mucosal melanoma? 2. Does location of...

ASCO University
Jan 16, 2017
Patient Case Update After discussion with the patient and his family, a decision was made to commence systemic therapy in place of...

Ryan J. Sullivan, MD
Jan 16, 2017
Course Faculty Response: Dr. Sullivan, MD CDKN2A is a gene that encodes for two proteins, P14ARF and P16INK4A, that function to regulate...

ASCO University
Jan 16, 2017
Course Faculty Response: Dr. Cushman-Vokoun, MD, PhD There are two FDA-approved assays for BRAF mutation testing in melanoma, both of...
Jan 13, 2017
This task force is indeed needed for equal access to good quality cancer care for patients. Good job in posting!! This is becoming...

Pages

Most Read

The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit enormously.
With new therapies, fortunately, oncologists are now seeing patients over the span of years, and we get to know the person who is the patient beyond their illness. Many also bring along others on visit after visit, and we get to know each of them too.
The new law, called the Medicare Quality Payment Program, not only promises to deliver a more consistent and reliable system of payment compared to the previous SGR, but also heralds a fundamental shift in CMS’s conception of reimbursement incentives.
Dr. Maher Saifo, an oncologist practicing in Syria, discusses how the Syrian war is affecting cancer care in a post written with his patient, Lama Meer Yousef. Together, they share their story of survival and hope against incredible odds.

Tweets from ASCO

Tweets from Oncology Community